Lung Cancer Clinical Trial Patient Recruitment

Lung cancer clinical trial recruitment for NSCLC, SCLC, and mesothelioma studies with rapid pre-screening and enrollment support.

Who qualifies: Adults with non-small cell or small cell lung cancer, including EGFR/ALK/ROS1 mutation-positive patients.

Recruitment challenges: Rapid disease progression requires fast enrollment timelines; molecular subtype matching adds complexity.

Our approach: Pulmonologist and oncologist referral networks, biomarker pre-screening partnerships, and expedited enrollment workflows.